Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?

× No keyword cloud information.

5 in total

Review 1. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Authors: Gillian M Keating; Katherine F Croom
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 2. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors: Richard Kones
Journal: Vasc Health Risk Manag Date: 2013-10-21

Review 3. Treatment of dyslipidemia in patients with type 2 diabetes.

Authors: Krishnaswami Vijayaraghavan
Journal: Lipids Health Dis Date: 2010-12-20 Impact factor: 3.876

Review 4. Actionable Metabolic Pathways in Heart Failure and Cancer-Lessons From Cancer Cell Metabolism.

Authors: Anja Karlstaedt; Walter Schiffer; Heinrich Taegtmeyer
Journal: Front Cardiovasc Med Date: 2018-06-19

5. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study.

Authors: Maria-Agata Miselli; Edoardo Dalla Nora; Angelina Passaro; Franco Tomasi; Giovanni Zuliani
Journal: Cardiovasc Diabetol Date: 2014-10-11 Impact factor: 9.951

5 in total